ARSA AcuerdoAcuerdo 0256-ARSA-2025
Acuerdo 0256-ARSA-2025 is the official ARSA identifier for “Regulación y control sanitario de los ensayos clínicos en seres humanos y cuotas de recuperación”. Acuerdo 0256-ARSA-2025 is the official identifier ARSA uses for this instrument.
- Instrument
- Acuerdo
- Full name
- Acuerdo 0256-ARSA-2025
- Category
- Clinical Trials
- Source publication
- Spanish
- Readable HTML
- 1 language version
- Published
- 2026-01-28
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Regulación y control sanitario de los ensayos clínicos en seres humanos y cuotas de recuperación
Complete original agreement published in La Gaceta 37055 on 28 January 2026, signed 5 December 2025. Expressly includes medical-device clinical trials, research-site licences, modifications, requirements, fees and decision periods. The closing clauses revoke Agreement 041-2020 and its amendments and amend the specified portions of Agreement 031-2021. Commences thirty days after Gazette publication. The extraction follows each Gazette column in order, taking only the right column of the first physical page and the left column of the last; neighbouring advertising and maize-flour instruments are excluded.
Acuerdo 0256-ARSA-2025 is the official identifier ARSA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.